Federal contract award
36C26125F0002
PLUVICTO PROSTATE CANCER THERAPY VANCHCS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 261-NETWORK CONTRACT OFFICE 21 (36C261) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0169 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.7M |
| Current contract value | $1.7M |
| Potential contract value / ceiling | $1.7M |
| Start date | Oct 1, 2024 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Apr 9, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 9, 2026 | P00003 | $-464.4K | DE-OB FY25 AND CLOSE OUT. PLUVICTO PROSTATE CANCER THERAPY VANCHCS - CLIN 0002 QUANTITY DECREASE. |
| Jun 11, 2025 | P00002 | $-1.0M | PLUVICTO PROSTATE CANCER THERAPY VANCHCS - CLIN 0002 QUANTITY DECREASE AND DEOBLIGATION. |
| Apr 11, 2025 | P00001 | $-1.2M | PLUVICTO PROSTATE CANCER THERAPY VANCHCS - DEOBLIGATION |
| Oct 1, 2024 | 0 | $4.4M | PLUVICTO PROSTATE CANCER THERAPY VANCHCS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.